The Certificate in Human Pharmacology

The Certificate in Human Pharmacology (CHP) is a 1-year part-time programme for doctors and scientists to attain a comprehensive knowledge of all aspects of exploratory studies of investigational medicinal products in man. The programme includes pharmacology applied to drug development, study design, basic pharmacokinetics, biomarkers of drug action, evaluation of new chemical entities, biological medicines and vaccines, safety, ethics and regulation. CHP will enable you to be better informed about the practicalities and underlying science of early studies of investigational medicines in humans.

Participants in the programme are required to attend two courses at King’s College, London. These cover exploratory drug development including ‘first-in-human’ studies (5 days) and drug development pharmacology (5 days) at an advanced level.  In addition to post-course tests and assignments, there is also an examination comprising a multiple-choice question paper administered by FPM.

You need to have a BSc (or higher qualification) in a relevant biological science or medical degree. You don’t have to be working in human pharmacology, though some basic knowledge of Phase I studies is really helpful. Applicants who don’t have a basic knowledge of Phase I studies may be recommended to attend a basic course in Clinical Pharmacology prior to registering for CHP.

The fee for enrolling on the CHP programme is £1000 which covers administration of the programme and the exam. Fees for the teaching and materials associated with the CHP courses are charged separately by the provider, King’s College London. The fee does not include travel or accommodation expenses.

The postponed March exam has been rescheduled to 26 October 2020. All FPM exams are being held online with remote invigilation in 2020. For more information go to COVID-19 and examinations.

Certificate in Human Pharmacology – MCQ exam 26 October 2020 09:30 – 12:30